Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B6, B12, and C for Microcirculation in Sepsis
NCT06749756Recruiting
- Start
- Feb 2025
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised trial of vitamin b6 for injection, vitamin b12 and ascorbic acid in sepsis (4 arms). Primary endpoint: Improvement of microcirculation at 7 days. Started Feb 2025; status: recruiting.
02
Drugs
vitamin b6 for injectionvitamin b12ascorbic acid
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT06749756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06749756.